The 2025 State of Pharma Launch Excellence Industry Report has just been released, and you can download it now.

The pharmaceutical landscape is evolving rapidly, with more launches failing than ever before. This brand new report - the most detailed and accurate to date - provides a full update on the current state of pharmaceutical launches, examining why these failures are occurring, which specific launches are struggling, and what strategies companies are implementing to overcome these challenges. This comprehensive analysis names key drugs, organisations, and insights to help you navigate regulatory hurdles and position your launches for success in this evolving landscape.

Download your complimentary copy of the brand new 45 page report now for an in-depth look at:

• How generative AI is transforming pharma launch strategies
• Key therapeutic areas like oncology, immunology, and obesity treatments leading future launches
• Navigating new regulatory challenges, including U.S. price controls and European reforms
• The critical role of cross-functional coordination in achieving launch success
• Why specialty drugs continue to dominate market growth
• The rise of independent launches by smaller biotech firms
• Addressing healthcare system capacity issues amid rising specialty drug costs
  

Dive into an exclusive interview with Sherif Elhaw, Pfizer's Launch Excellence Lead for Emerging Markets. With over two decades of experience in pharmaceuticals, Sherif shares his journey, the evolution of launch strategies, and the pivotal role of innovation in overcoming industry challenges. Gain valuable insights into navigating the complexities of product launches and discover how to harness critical thinking and data analytics for successful outcomes. Download this content to empower your approach to drug launches and stay ahead in the dynamic pharmaceutical landscape. Don't miss the opportunity to learn from a leader at the forefront of healthcare innovation!

#PHLEX is set to unite the global launch community to navigate post-pandemic challenges in a competitive digital and regulatory environment, optimising strategy for successful product commercialisation. See who you could be connecting with at the Pharma Launch Excellence Summit this December in London! 

Get your complimentary copy below 

[Speaker Interview] Paula Albuquerque, Assets Strategic Planning, at UCB shares insights on evolving landscape of launch excellence, highlighting the importance of strategic agility, market access collaboration, and sustainable practices to ensure both corporate success and equitable patient outcomes.

[Speaker Video Interview] Simone Rebora, Global Marketing Director at Ipsen shares insights on building expertise, evolving in the industry, mastering successful launches and adapting global launch strategies.